Tetrahydrocannabinol News and Research

RSS

The pluses and minuses of allowing medical marijuana at school

Every school day at noon, Karina Garcia drives to her son’s South San Francisco high school to give him a dose of cannabis oil to prevent potentially life-threatening seizures.

30 Aug 2018

Component of cannabis could help in psychosis

Researchers from King’s College London have now found how the chemical cannabidiol or CBD from cannabis can reduce the abnormal brain activity in patients who are at risk of psychosis. The study was published in the latest issue of the journal JAMA Psychiatry.

30 Aug 2018

Study finds traces of marijuana in breast milk up to six days after use

With the legalization of marijuana in several states, increased use for both medicinal and recreational purposes has been documented in pregnant and breastfeeding women.

27 Aug 2018

Marijuana detection using a breath-analyzer

Marijuana is being increasingly legalized across several states and its use is also on the rise. While 9 states and District of Columbia have legalized recreational marijuana, 30 states and D.C. have legalized medicinal marijuana use.

5 Aug 2018

UCI receives $9 million grant to find long-term impact of cannabis exposure on adolescent brain

The National Institute on Drug Abuse, part of the National Institutes of Health, has awarded the University of California, Irvine School of Medicine, a 4-year, $9 million grant aimed at determining the long-term impact of cannabis exposure on the adolescent brain.

30 Jul 2018

Animal studies reveal brain changes responsible for appetite effects of cannabis

New research on how cannabis use alters eating behavior could lead to treatments for appetite loss in chronic illness, according to experts at Washington State University.

17 Jul 2018

FDA approves cannabis based drug for severe form of epilepsy

The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.

28 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

Early-onset cannabis use linked to further drug abuse problems

What a difference a year or two can make: If you started smoking marijuana at the start of your teens, your risk of having a drug abuse problem by age 28 is 68 per cent, but if you started smoking between 15 and 17 your risk drops to 44 per cent, according to a new study by Université de Montréal researchers.

21 May 2018

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder.

27 Apr 2018

New app could improve safety of cannabis use

Although cannabis, also known as marijuana, has been shown to impair memory, reaction time and attention, it is difficult to assess this impairment in a natural setting. Researchers have developed a prototype app called 'Am I Stoned' that could help cannabis users understand how the drug is affecting them through a series of phone-based tasks.

25 Apr 2018

Studies show hemp's potential for treating ovarian cancer

Results from some of the first studies to examine hemp's ability to fight cancer show that it might one day be useful as plant-based treatment for ovarian cancer. Hemp is part of the same cannabis family as marijuana but doesn't have any psychoactive properties or cause addiction.

24 Apr 2018

Study provides guidance on using cannabis for treatment of stress, anxiety, and depression

In a first-of-a-kind study, Washington State University scientists examined how peoples' self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home.

20 Apr 2018

Cannabis use triggers schizophrenia and other psychiatric issues

Schizophrenia and other psychiatric issues may be triggered by marijuana use, according to a research analysis in the Journal of the American Osteopathic Association.

12 Feb 2018

As marijuana laws relax, doctors say pregnant women shouldn’t partake

Two-year-old Maverick Hawkins sits on a red, plastic car in his grandmother’s living room in the picturesque town of Nevada City, Calif., in the foothills of the Sierra Nevada. His playpal Delilah Smith, a fellow 2-year-old, snacks on hummus and cashews and delights over the sounds of her Princess Peppa Pig stuffie.

31 Jan 2018

Chemical found in marijuana could help HIV patients maintain their mental function

A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.

12 Dec 2017

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

A synthetic cannabis-like drug in a pill was safe and effective in treating obstructive sleep apnea in the first large multi-site study of a drug for apnea funded by the National Institutes of Health. The study was conducted at Northwestern Medicine and the University of Illinois at Chicago.

28 Nov 2017

Tetrahydrocannabinol News and Research

The pluses and minuses of allowing medical marijuana at school

Component of cannabis could help in psychosis

Study finds traces of marijuana in breast milk up to six days after use

Marijuana detection using a breath-analyzer

UCI receives $9 million grant to find long-term impact of cannabis exposure on adolescent brain

Animal studies reveal brain changes responsible for appetite effects of cannabis

FDA approves cannabis based drug for severe form of epilepsy

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

Early-onset cannabis use linked to further drug abuse problems

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

New app could improve safety of cannabis use

Studies show hemp's potential for treating ovarian cancer

Study provides guidance on using cannabis for treatment of stress, anxiety, and depression

Cannabis use triggers schizophrenia and other psychiatric issues

As marijuana laws relax, doctors say pregnant women shouldn’t partake

Chemical found in marijuana could help HIV patients maintain their mental function

Synthetic cannabis-like drug found to be safe and effective in treating sleep apnea

Pre-clinical study reports promising step forward in search for non-addictive painkillers

Systematic review finds lack of data on medical cannabis use in children and adolescents

Your grandma’s guide to grass: Calif. rolls out website to cut through cannabis haze

Cannabis Testing & Analysis eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News